Thursday, May 8, 2025

Latest

FSD Pharma Fires President, Certain Shareholders Look To Takeover Company

FSD Pharma (CSE: HUGE) (NASDAQ: HUGE) last night issued a corporate update, indicating that it has fired the president of the company, Zeeshan Saeed, for cause. The company however did not indicate what specifically the justification for the termination was however.

FSD Pharma Logo

In connection with his termination, which is effective immediately, Saeed is deemed to have resigned from all other positions with the company and its subsidiaries as well. This includes his role on the firms board of directors.

While not stated specifically, it is believed the termination may be in connection with a contested shareholders meeting. The company subsequently announced last night within the same release that a requisition for a special meeting was submitted to the company by certain shareholders, whom hold in excess of 5.1% of the firms 19.2 million outstanding Class B subordinate shares.

Shareholders involved within the requisition include Zeeshan Saeed as well as that of Anthony Durkacz, whom is a director of the firm. While their Class B portion of the shares may remain small, each of them also hold 24 Class A multiple voting shares, while the firms CEO and Executive Chairman, Raza Bokhari, also owns 24, with a total of 72 of Class A shares being outstanding. Each Class A share amounts to 276,660 votes. Effectively, this gives Saeed and Durkacz control of the company if they elect to work together.

The requisitioning shareholders evidently are looking to reduce the size of the firms board of directors to five, while replacing six of the incumbent directors, which includes Executive Chairman Raza Bokhari. The shareholders will then select three directors for the board. Effectively, it appears that the shareholders are not satisfied with the direction of the company, and as a result are looking to take control.

FSD Pharma last traded at $2.75 on the CSE.


Information for this briefing was found via Sedar, and FSD Pharma. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Giant Mining Encounters Native Copper As Hole MHB-34 Hits 563 Metres Depth

Related News

Auxly Cannabis Clarifies FSD Pharma Joint Venture Termination

Auxly Cannabis (TSXV: XLY, OTCMKTS: CBWTF) clarified yesterday the termination of its joint venture with...

Friday, February 8, 2019, 02:00:35 PM

FSD Pharma To Forfeit Cannabis License, Liquidate FV Pharma To Focus On Coronavirus

FSD Pharma (CSE: HUGE) (NASDAQ: HUGE) this morning announced that it is going all in...

Thursday, July 30, 2020, 08:25:40 AM

FSD Pharma Issues Additional Shares To Solarvest BioEnergy

FSD Pharma (CSE: HUGE) (NASDAQ: HUGE) announced this morning that the firm has signed an...

Tuesday, February 4, 2020, 08:52:51 AM

World Class Extractions: Pending Listing & FSD Connections

It was announced yesterday that World Class Extractions had received conditional approved from the Canadian...

Tuesday, March 12, 2019, 02:00:20 PM

FSD Pharma Severs Ties with Auxly Cannabis

FSD Pharma (CSE: HUGE, OTCMKTS: FSDDF) announced late last night that it had cut ties...

Thursday, February 7, 2019, 02:00:36 PM